Hewlett Packard Enterprise's latest narrative shift comes with a steady fair value near $26.28 per share, but subtle changes under the surface are reshaping how investors view its risk and growth ...
John Paulson’s Q3 2025 13F portfolio surged to ~$2.97B, concentrated in just 10 securities, with Madrigal Pharma (MDGL) as the largest position. MDGL, now ~30% of the portfolio, was trimmed by ~9% but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback